ANI PHARMACEUTICALS, INC Payments of Stock Issuance Costs
ANI PHARMACEUTICALS, INC (ANIP) reported Payments of Stock Issuance Costs of $5.42 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-09
- ANI PHARMACEUTICALS, INC payments of stock issuance costs for the quarter ending 2014-06-30 was $0.00.
- ANI PHARMACEUTICALS, INC payments of stock issuance costs for the quarter ending 2014-03-31 was $3.30M.
- ANI PHARMACEUTICALS, INC payments of stock issuance costs for fiscal 2021 was $5.42M.
- ANI PHARMACEUTICALS, INC payments of stock issuance costs for fiscal 2020 was $0.00.
- ANI PHARMACEUTICALS, INC payments of stock issuance costs for fiscal 2019 was $0.00.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $5.42M 10-K · filed 2023-03-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.30M 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | $3.30M 10-Q · filed 2014-05-12 | |||
| 2014-03-10 | $3.30M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |